97 related articles for article (PubMed ID: 11599799)
1. Inhibition of endothelial cell proliferation and tumor-induced angiogenesis by pentoxifylline.
Gude RP; Binda MM; Boquete AL; Bonfil RD
J Cancer Res Clin Oncol; 2001 Oct; 127(10):625-30. PubMed ID: 11599799
[TBL] [Abstract][Full Text] [Related]
2. Studies on the mechanisms responsible for inhibition of experimental metastasis of B16-F10 murine melanoma by pentoxifylline.
Gude RP; Binda MM; Presas HL; Klein-Szanto AJ; Bonfil RD
J Biomed Sci; 1999; 6(2):133-41. PubMed ID: 10087444
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative and antiproteolytic activity of pentoxifylline in cultures of B16F10 melanoma cells.
Dua P; Gude RP
Cancer Chemother Pharmacol; 2006 Aug; 58(2):195-202. PubMed ID: 16331498
[TBL] [Abstract][Full Text] [Related]
4. VGA1155, a novel binding antagonist of VEGF, inhibits angiogenesis in vitro and in vivo.
Ueda Y; Yamagishi T; Ikeya H; Hirayama N; Itokawa T; Aozuka Y; Samata K; Nakaike S; Tanaka M; Ono M; Saiki I
Anticancer Res; 2004; 24(5A):3009-17. PubMed ID: 15517909
[TBL] [Abstract][Full Text] [Related]
5. Suramin augments the antitumor and antimetastatic activity of pentoxifylline in B16F10 melanoma.
Dua P; Ingle A; Gude RP
Int J Cancer; 2007 Oct; 121(7):1600-8. PubMed ID: 17582610
[TBL] [Abstract][Full Text] [Related]
6. Pentoxifylline inhibits human T-cell adhesion to dermal endothelial cells.
Bruynzeel I; van der Raaij LM; Willemze R; Stoof TJ
Arch Dermatol Res; 1997 Mar; 289(4):189-93. PubMed ID: 9143734
[TBL] [Abstract][Full Text] [Related]
7. Pentoxifylline inhibits melanoma tumor growth and angiogenesis by targeting STAT3 signaling pathway.
Kamran MZ; Gude RP
Biomed Pharmacother; 2013 Jun; 67(5):399-405. PubMed ID: 23639230
[TBL] [Abstract][Full Text] [Related]
8. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
Min HY; Doyle LV; Vitt CR; Zandonella CL; Stratton-Thomas JR; Shuman MA; Rosenberg S
Cancer Res; 1996 May; 56(10):2428-33. PubMed ID: 8625323
[TBL] [Abstract][Full Text] [Related]
9. Responses of vascular endothelial cells to angiogenic signaling are important for tumor cell survival.
Shan S; Robson ND; Cao Y; Qiao T; Li CY; Kontos CD; Garcia-Blanco M; Dewhirst MW
FASEB J; 2004 Feb; 18(2):326-8. PubMed ID: 14688196
[TBL] [Abstract][Full Text] [Related]
10. Determinants for in vivo antitumor effect of angiogenesis inhibitor SU5416 formulated in PEGylated emulsion.
Ogawara K; Abe S; Un K; Yoshizawa Y; Kimura T; Higaki K
J Pharm Sci; 2014 Aug; 103(8):2464-9. PubMed ID: 24985750
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of Physalis angulata on tumor metastasis and angiogenesis.
Hseu YC; Wu CR; Chang HW; Kumar KJ; Lin MK; Chen CS; Cho HJ; Huang CY; Huang CY; Lee HZ; Hsieh WT; Chung JG; Wang HM; Yang HL
J Ethnopharmacol; 2011 Jun; 135(3):762-71. PubMed ID: 21515352
[TBL] [Abstract][Full Text] [Related]
12. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
Sheu JR; Fu CC; Tsai ML; Chung WJ
Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
[TBL] [Abstract][Full Text] [Related]
13. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
Yeh CH; Peng HC; Yang RS; Huang TF
Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
[TBL] [Abstract][Full Text] [Related]
14. Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities.
Koyanagi S; Tanigawa N; Nakagawa H; Soeda S; Shimeno H
Biochem Pharmacol; 2003 Jan; 65(2):173-9. PubMed ID: 12504793
[TBL] [Abstract][Full Text] [Related]
15. New nortriterpenoid isolated from anti-rheumatoid arthritic plant, Tripterygium wilfordii, modulates tumor growth and neovascularization.
Ushiro S; Ono M; Nakayama J; Fujiwara T; Komatsu Y; Sugimachi K; Kuwano M
Int J Cancer; 1997 Aug; 72(4):657-63. PubMed ID: 9259407
[TBL] [Abstract][Full Text] [Related]
16. Modulation of inflammatory response by pentoxifylline is independent of heme oxygenase-1 pathway.
Taha H; Grochot-Przeczek A; Was H; Kotlinowski J; Kozakowska M; Marek A; Skrzypek K; Lackowska B; Balcerczyk A; Mustafa S; Dulak J; Jozkowicz A
J Physiol Pharmacol; 2009 Jun; 60(2):3-12. PubMed ID: 19617639
[TBL] [Abstract][Full Text] [Related]
17. Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts.
Strutz F; Heeg M; Kochsiek T; Siemers G; Zeisberg M; Müller GA
Nephrol Dial Transplant; 2000 Oct; 15(10):1535-46. PubMed ID: 11007820
[TBL] [Abstract][Full Text] [Related]
18. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
19. Blocking angiogenesis and tumorigenesis with GFA-116, a synthetic molecule that inhibits binding of vascular endothelial growth factor to its receptor.
Sun J; Blaskovich MA; Jain RK; Delarue F; Paris D; Brem S; Wotoczek-Obadia M; Lin Q; Coppola D; Choi K; Mullan M; Hamilton AD; Sebti SM
Cancer Res; 2004 May; 64(10):3586-92. PubMed ID: 15150116
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models.
Clemente N; Argenziano M; Gigliotti CL; Ferrara B; Boggio E; Chiocchetti A; Caldera F; Trotta F; Benetti E; Annaratone L; Ribero S; Pizzimenti S; Barrera G; Dianzani U; Cavalli R; Dianzani C
Front Pharmacol; 2019; 10():776. PubMed ID: 31354491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
